This move follows the suspension of TMC's group CEO Wan Nadiah Binti Wan Mohd Abdullah Yaakob with effect from Jan 29 until further notice.
Dr Melvin Heng, group CEO of Thomson Medical, has been appointed acting group CEO of the company's separately listed subsidiary TMC Life Sciences.
Heng is now a non-executive, non-independent director of TMC, which is listed in Malaysia.
